School of Medicine
Showing 1,041-1,060 of 13,036 Results
-
Kameron C. Black
Fellow in Peds/Clinical Informatics
BioDr. Kameron Black is an ABIM board-certified, first-generation Latino physician-scientist and clinical informatics fellow with a commitment to the safe deployment of agentic artificial intelligence in real-world healthcare systems. He completed his internal medicine residency at Oregon Health & Science University (OHSU) and is currently in a fellowship program in clinical informatics at Stanford University, expected to graduate in 2026. His work has been covered by Forbes, Bloomberg, Anthropic (“The Briefing: Healthcare and Life Sciences” virtual event) and the Stanford Institute for Human-Centered AI (HAI). He has also served as a featured panelist and invited speaker at several events focused on agentic AI in healthcare, including AAHCM, The Healthcare Agent Summit hosted by Wedge Inc., and the AVIA Nexus collaborative series.
Research interests: implementation of agentic AI in healthcare workflows (NEJM AI, DOI: 10.1056/AIdbp2500144 & JMIR AI, DOI: 10.2196/66741), virtual care model innovation, mitigation of bias in CDS tools, and data-driven quality improvement. Dr. Black holds an MPH in community and behavioral health, which enhances his focus on health equity initiatives.
Current and prior research affiliations: Massachusetts General Hospital, Harvard Medical School, and Johns Hopkins University. His scholarly contributions have been published in journals including Nature Scientific Data, JMIR, NEJM AI, and Applied Clinical Informatics.
Clinical experience: academic medical centers, safety net FQHC hospitals, and Kaiser Permanente.
EHR proficiency: Epic Systems Physician Builder certified, Cosmos Data Science & Super User certified, as well as Cosmos Researcher badge completed.
Additional areas of research focus: Healthcare AI Agents, Medical AI Benchmarking, Clinical Workflow Automation, Healthcare Administrative Burden, Physician Burnout, Healthcare Workforce Shortage.
Eph 2:8-9
Gal 1:10 -
Brian Blackburn
Clinical Professor, Medicine - Infectious Diseases
Current Research and Scholarly InterestsMy interests include parasitology and global health; I've investigated cryptosporidium and angiostrongylus outbreaks; schistosoma/strongyloides seroprevalence in refugees, and the distribution and impact of ITNs for malaria and filariasis prevention in Nigeria and India. I have done clinical and programmatic work at teaching hospitals in Liberia and Bangladesh and have opportunities for research in Bangladesh and Kenya, in collaboration with ICDDR,B and CDC, Kenya
-
Alexandria Blacker
Program Director - Community Partnership, Medicine
BioAlexandria Blacker, PhD, MPH is the Director of the Stanford Department of Medicine’s Community Partnership Program and adjunct fauclty in the Milken School of Public Health at George Washington University. As a public health professional, Dr. Blacker has worked in breast cancer behavioral research, primary care redesign, community health, health care worker well-being, and program implementation.
In her current role, she focuses on building bi-directional, equitable, and sustainable partnerships to advance local health equity. Dr. Blacker’s research focuses on understanding processes to developing sustainable community-academic partnerships and exploring the complexity of interprofessional health care teams including teaming behaviors and contextual influences.
Dr. Blacker has had the pleasure of working with Stanford in both the health care and University settings. As a Stanford Health Care employee, Dr. Blacker worked for the Stanford Coordinated Care clinic and managed the disease management program for employees and staff. She also worked closely with her colleagues to assist in the change management efforts for the Primary Care 2.0 redesign implementation by developing educational curriculum and go-live execution with physicians, clinic managers, and team members.
As a University employee, Dr. Blacker previously worked as part of the HealthySteps to Wellness team as the Wellness Manager for Stanford Health Care. In this role, she worked cross-functionally with department heads to design and manage wellness-based trainings. She has developed curricula in positive psychology, stress management, and behavior change. She has conducted over 100 trainings and conducted programmatic evaluations to streamlining processes to increase overall effectiveness. -
Andreas Blaha
Postdoctoral Scholar, Molecular and Cellular Physiology
BioOriginally from a tiny village in Northern Germany, Andreas moved to the city for his bachelor’s from the University of Hamburg. After graduating with a master’s in biochemistry from the University of Tübingen in Southwestern Germany, Andreas moved abroad for his PhD to Vienna, Austria. At the Research Institute of Molecular Pathology (IMP), he discovered a complex on the sperm surface that connects to the egg membrane. Having studied the function of intricate membrane protein complexes, Andreas made the journey overseas to join the Pleiner lab and investigate how the cell manages and coordinates their production. In his free time, Andreas enjoys hiking in summer and skiing in winter.
-
Britney Blair, PsyD, DBSM, CST
Adjunct Clinical Instructor, Psychiatry and Behavioral Sciences - Sleep Medicine
BioDr. Blair is a licensed clinical psychologist and is board certified in behavioral sleep medicine. Her clinical and research expertise are in behavioral medicine with specializations in sleep and sexual health. She has made numerous presentations, developed workshops, written chapters and published articles in the area of sleep and sexual medicine. Dr. Blair is a Stanford sleep consultant and is on the adjunct faculty at The Stanford Center for Sleep Sciences and Medicine. She is also the Clinical Director of The Clinic.
Dr. Blair completed her postdoctoral fellowship at Stanford University Medical School and her pre-doctoral internship at the VA Greater Los Angeles Health Care System. Dr. Blair received her doctoral degree in Clinical Psychology from the PGSP-Stanford Psy.D. Consortium. She received a bachelor’s degree from the University of California at Berkeley. Prior to beginning her doctoral studies, Dr. Blair founded a successful business consulting firm. -
Richard Bland
Professor (Research) of Pediatrics (Neonatology), Emeritus
Current Research and Scholarly InterestsOur research focuses on the pathogenesis and treatment of acute and chronic neonatal lung injury and the mechanisms that regulate lung fluid balance and alveolar & pulmonary vascular development after premature birth.
-
Francis Blankenberg
Associate Professor of Radiology (Pediatric Radiology) and, by courtesy, of Pediatrics
Current Research and Scholarly InterestsStudies on apoptotic cell death in vivo using the H MRS phenomenon.
-
Rebecca Blankenburg, MD, MPH
Clinical Professor, Pediatrics
Current Research and Scholarly InterestsMy educational research interests focus on building a more diverse, inclusive and equitable learning environment and helping develop a sense of belonging, professional identity formation, and competence through longitudinal coaching and scholarly mentorship.
-
Terrence Blaschke
Professor of Medicine and of Molecular Pharmacology, Emeritus
Current Research and Scholarly InterestsClinical pharmacology of antiretroviral drugs
Pharmacokinetic and pharmacodynamic mechanisms of variability in drug response.
Drug development -
Helen M. Blau
Donald E. and Delia B. Baxter Foundation Professor, Director, Baxter Laboratory for Stem Cell Biology and Professor, by courtesy, of Psychiatry and Behavioral Sciences
Current Research and Scholarly InterestsProf. Helen Blau's research area is regenerative medicine with a focus on stem cells. Her research on nuclear reprogramming and demonstrating the plasticity of cell fate using cell fusion is well known and her laboratory has also pioneered the design of biomaterials to mimic the in vivo microenvironment and direct stem cell fate. Current findings are leading to more efficient iPS generation, cell based therapies by dedifferentiation a la newts, and discovery of novel molecules and therapies.
